image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Craneware

March 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRW
  • Price:
  • 330p
Craneware has disappointed the market with its half year update noting that while revenues increased 12%, adjusted EBITDA will be in line with last year (H1 2011: US$4.6m). However if the recent acquisition, Craneware Insight, had not been included, adjusted EBITDA would have risen over 15%. Craneware noted that despite continued growth in the sales pipeline, sales cycles have extended for all the group's product families. This is due to “an unexpectedly high percentage of healthcare providers focusing on achieving the 31 December 2011 deadline for the First Electronic Health Records Incentive payments.†Apparently now that this deadline has passed and with far fewer US hospitals remaining to apply in 2012, management expects s ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Craneware (September 2013)
Craneware (November 2012)
Craneware - Second downgrade this year (August 2012)
Craneware (November 2011)
Craneware - New contract wins (September 2011)
Craneware - Acquistion raises forecasts (April 2011)
Craneware - Another amazing share price spike (December 2010)
Craneware - Shares spike vertically by over £1 (October 2010)
Craneware (June 2010)
Craneware - Billing software firm enjoying quick-fire growth (February 2010)
Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X